CO2024007641A2 - Mutación del genoma completo de molécula única y perfiles de fragmentación de ácido desoxirribonucleico (adn) libre de célula - Google Patents

Mutación del genoma completo de molécula única y perfiles de fragmentación de ácido desoxirribonucleico (adn) libre de célula

Info

Publication number
CO2024007641A2
CO2024007641A2 CONC2024/0007641A CO2024007641A CO2024007641A2 CO 2024007641 A2 CO2024007641 A2 CO 2024007641A2 CO 2024007641 A CO2024007641 A CO 2024007641A CO 2024007641 A2 CO2024007641 A2 CO 2024007641A2
Authority
CO
Colombia
Prior art keywords
fragmentation
profiling
dna
cell
deoxyribonucleic acid
Prior art date
Application number
CONC2024/0007641A
Other languages
English (en)
Inventor
Victor E Velculescu
Robert B Scharpf
Daniel C Bruhm
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of CO2024007641A2 publication Critical patent/CO2024007641A2/es

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Theoretical Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pathology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Artificial Intelligence (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Primary Health Care (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

La presente invención se refiere a métodos para la detección de cáncer no invasivo que usan una combinación de características de mutación y fragmentación de todo el genoma del ADNcf que facilitan la detección del cáncer.
CONC2024/0007641A 2021-12-15 2024-06-18 Mutación del genoma completo de molécula única y perfiles de fragmentación de ácido desoxirribonucleico (adn) libre de célula CO2024007641A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163290017P 2021-12-15 2021-12-15
PCT/US2022/053052 WO2023114426A1 (en) 2021-12-15 2022-12-15 Single molecule genome- wide mutation and fragmentation profiles of cell-free dna

Publications (1)

Publication Number Publication Date
CO2024007641A2 true CO2024007641A2 (es) 2024-09-09

Family

ID=86773474

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2024/0007641A CO2024007641A2 (es) 2021-12-15 2024-06-18 Mutación del genoma completo de molécula única y perfiles de fragmentación de ácido desoxirribonucleico (adn) libre de célula

Country Status (6)

Country Link
CN (1) CN118660974A (es)
AU (1) AU2022410636A1 (es)
CA (1) CA3238944A1 (es)
CO (1) CO2024007641A2 (es)
IL (1) IL313476A (es)
WO (1) WO2023114426A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201818159D0 (en) * 2018-11-07 2018-12-19 Cancer Research Tech Ltd Enhanced detection of target dna by fragment size analysis
EP4055187A4 (en) * 2019-11-06 2023-11-01 The Board of Trustees of the Leland Stanford Junior University METHOD AND SYSTEMS FOR ANALYZING NUCLEIC ACID MOLECULES

Also Published As

Publication number Publication date
IL313476A (en) 2024-08-01
AU2022410636A1 (en) 2024-06-06
CN118660974A (zh) 2024-09-17
WO2023114426A1 (en) 2023-06-22
CA3238944A1 (en) 2023-06-22

Similar Documents

Publication Publication Date Title
EA201991369A1 (ru) Модифицированные направляющие рнк
WO2018195545A3 (en) Variants of cpf1 (cas12a) with altered pam specificity
WO2022155530A8 (en) Variant strain-based coronavirus vaccines
EP1931806A4 (en) PKR ACTIVATION BY HYBRIDIZATION CHAIN REACTION
EA201792663A1 (ru) Способы скрининга бактерий, архей, водорослей и дрожжей с использованием нуклеиновых кислот crispr
WO2016106400A3 (en) Rna interference agents for gst-pi gene modulation
MX2018000729A (es) Métodos para amplificar las secuencias de ácido nucleico.
MX2024006956A (es) Inserciones de adn no virales orientadas.
PH12015502362A1 (en) Certain chemical entities, compositions and methods
IN2014DN01605A (es)
CY1117546T1 (el) Eνωση διαμινο ετεροκυκλικου καρβοξαμιδιου
NZ607996A (en) Substituted nucleotide analogs
EA201190178A1 (ru) Замещённые нуклеозидные и нуклеотидные аналоги
MX2021001590A (es) Oligonucleótidos modificados dirigidos a snp.
EP4275697A3 (en) Optimized engineered nucleases having specificity for the human t cell receptor alpha constant region gene
GB2489187A (en) Compositions,methods and related uses for cleaving modified DNA
MX2021006745A (es) Constructos de iarn modificados quimicamente y usos de estos.
BRPI0517131A2 (pt) mÉtodos para simplificar Ácidos nuclÉicos microbiais por modificaÇço quÍmica de citosinas
ATE505562T1 (de) Doppel-oligonukleotid- nukleinsäurenachweisverfahren
EP3633381A3 (en) Compositions and methods for identifying and treating cachexia or pre-cachexia
DOP2010000101A (es) Nuevos inhibidores de epoxido hidrolasas soluble (seh) y procedimientos
BR112014014656A2 (pt) processo inovador de cultivo de bactéria para aprimoramento de produtividade de polioses capsulares
MX2009011215A (es) Derivados de triazolopiridina carboxamida, su preparacion y su aplicacion terapeutica.
CY1116538T1 (el) Αναλογα ολιγονουκλεοτιδιου τροποποιημενα με φωσφορικο με ανοσοδιεγερτικη δραστικοτητα
MX2022001710A (es) Oligonucleótidos modificados químicamente dirigidos a los snp.